Wegovy vs Mounjaro Starter Dose UK - Compare Prices

Clinically Proven UK Registered Pharmacy

Wegovy vs Mounjaro Starter Dose - Cheapest UK Prices

Compare starter doses at the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy vs Mounjaro Starter Dose: UK Comparison Guide

Understanding the wegovy vs mounjaro starter dose differences is essential for anyone beginning their weight loss journey with GLP-1 receptor agonist therapy. Wegovy (semaglutide) initiates treatment at 0.25mg weekly, while Mounjaro (tirzepatide) begins at 2.5mg weekly, reflecting fundamentally different titration strategies despite both requiring gradual dose escalation. Our UK-registered clinical team at Cured Pharmacy has guided thousands of patients through these treatment pathways, and this comprehensive comparison will clarify which starter dose protocol may suit your individual needs, subject to prescriber approval.

What Are the Wegovy vs Mounjaro Starter Dose Protocols?

The wegovy vs mounjaro starter dose protocols differ significantly in their initial dosing strategies, though both follow a carefully designed escalation schedule to minimise gastrointestinal side effects whilst optimising therapeutic response. Wegovy begins at 0.25mg administered subcutaneously once weekly for the first four weeks, then increases to 0.5mg for weeks 5-8, followed by 1mg for weeks 9-12, 1.7mg for weeks 13-16, and finally reaching the maintenance dose of 2.4mg from week 17 onwards [1]. This gradual five-step titration allows the body to adapt progressively to semaglutide's effects on gastric emptying and appetite regulation.

Mounjaro's starter dose begins at 2.5mg once weekly for the initial four weeks, then escalates to 5mg for the subsequent four-week period, with further increases available to 7.5mg, 10mg, 12.5mg, and a maximum of 15mg depending on individual response and tolerability [2]. Despite the higher absolute milligram value of Mounjaro's starter dose compared to Wegovy's 0.25mg, these medications cannot be directly compared by dosage alone due to their different molecular structures—tirzepatide is a dual GIP/GLP-1 receptor agonist whilst semaglutide is a selective GLP-1 receptor agonist, meaning their pharmacological potency differs fundamentally. Both titration schedules are evidence-based protocols developed through extensive clinical trials and approved by the MHRA for weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities.

Why Starter Doses Matter in Wegovy vs Mounjaro Treatment

The carefully calibrated starter doses in the wegovy vs mounjaro comparison serve a critical clinical purpose beyond simply introducing the medication gradually. Research demonstrates that abrupt initiation at higher doses significantly increases the incidence and severity of gastrointestinal adverse events including nausea, vomiting, diarrhoea, and constipation, which are the primary reasons for treatment discontinuation [3]. The starter dose period allows patients to develop physiological tolerance to delayed gastric emptying whilst establishing sustainable dietary modifications that complement the medication's appetite-suppressing effects. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) advises patients that adherence to the prescribed starter dose schedule, rather than rushing to higher doses, correlates with better long-term weight loss outcomes and treatment persistence.

Wegovy vs Mounjaro Starter Dose: Efficacy Comparison

When comparing wegovy vs mounjaro starter dose efficacy, it's essential to understand that meaningful weight loss typically begins during the escalation phase rather than at the initial starter dose itself. In the STEP 1 trial, participants using Wegovy achieved an average weight reduction of approximately 5.9% by week 20 (during the dose escalation period) and 14.9% by week 68 at the 2.4mg maintenance dose [1]. The starter doses of 0.25mg and 0.5mg during weeks 1-8 primarily serve to establish tolerability whilst initiating modest appetite suppression and early behavioural changes.

Mounjaro demonstrated superior weight loss outcomes in head-to-head comparison, with the SURMOUNT-1 trial showing average weight reductions of 15.0% at the 5mg dose, 19.5% at the 10mg dose, and 20.9% at the 15mg dose over 72 weeks [2]. Importantly, participants on Mounjaro's starter dose of 2.5mg during the initial four weeks typically experience earlier onset of appetite suppression compared to Wegovy's 0.25mg starter dose, though this does not necessarily predict final weight loss outcomes. The SURMOUNT-2 trial specifically in participants with type 2 diabetes showed tirzepatide achieved 12.8% weight loss at 10mg versus 6.7% with semaglutide 1mg, though direct comparison with Wegovy's 2.4mg dose requires consideration of the different trial populations [4].

Clinical experience at Cured Pharmacy indicates that individual response to the wegovy vs mounjaro starter dose varies considerably based on baseline metabolic factors, adherence to lifestyle modifications, and genetic variations in GLP-1 receptor sensitivity. Approximately 10-15% of patients may experience substantial appetite suppression even at starter doses, whilst others require escalation to higher maintenance doses before achieving clinically significant weight loss. All weight loss outcomes remain subject to prescriber approval and require ongoing clinical monitoring throughout treatment.

Side Effects During Wegovy vs Mounjaro Starter Dose Phase

The side effect profile during the wegovy vs mounjaro starter dose phase represents a critical consideration for treatment selection and patient counselling. Wegovy's 0.25mg starter dose produces gastrointestinal side effects in approximately 44% of patients, with nausea being most common (20%), followed by diarrhoea (9%), vomiting (5%), and constipation (7%) during the initial four weeks [1]. The lower absolute dose allows many patients to adapt gradually, with symptom severity typically peaking during dose escalations rather than at the starter dose itself.

Mounjaro's 2.5mg starter dose demonstrates a comparable side effect frequency, with nausea reported in 17-22% of participants, diarrhoea in 17-19%, and vomiting in 6-10% during the SURMOUNT trials [2]. Despite the higher milligram amount compared to Wegovy's starter dose, the incidence of gastrointestinal adverse events remains similar due to tirzepatide's different receptor binding profile and pharmacokinetics. Importantly, most side effects during both starter dose phases are mild to moderate in severity and typically resolve within 4-8 weeks as physiological adaptation occurs.

Our clinical team advises patients that managing side effects during the wegovy vs mounjaro starter dose period significantly improves treatment persistence. Evidence-based strategies include eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection on the same day each week to establish routine. Approximately 4-7% of patients discontinue treatment during the starter dose phase due to intolerable side effects, though this rate decreases substantially when patients receive comprehensive pre-treatment counselling and ongoing clinical support [3]. Any persistent or severe symptoms warrant immediate consultation with your prescriber to assess whether dose adjustment or alternative treatment is appropriate.

Managing Nausea During Starter Dose Escalation

Nausea management during the wegovy vs mounjaro starter dose phase requires proactive dietary modifications and, when necessary, pharmacological intervention. Clinical trials demonstrate that eating slowly, stopping when comfortably satisfied rather than full, and avoiding lying down immediately after meals reduces nausea incidence by approximately 30-40% [3]. If nausea persists despite these measures, UK prescribers may recommend anti-emetic medications such as domperidone or metoclopramide for short-term use, though these require separate prescription and clinical assessment. Patients should never increase the time between doses or skip injections to avoid nausea, as this disrupts the therapeutic protocol and may increase side effects when resuming treatment.

Feature Wegovy Mounjaro
Starter Dose 0.25mg weekly 2.5mg weekly
Active Ingredient Semaglutide Tirzepatide
Mechanism GLP-1 agonist Dual GIP/GLP-1 agonist
Starter Duration 4 weeks 4 weeks
Escalation Steps 5 doses to maintenance Up to 6 doses available
Maintenance Dose 2.4mg weekly 5-15mg weekly
Time to Maintenance 16 weeks 8+ weeks
Average Weight Loss 14.9% at 68 weeks 20.9% at 72 weeks (15mg)
Starting Price (UK) From £119.00 From £145.00
Nausea Incidence 20% at starter dose 17-22% at starter dose

Wegovy vs Mounjaro Starter Dose: UK Pricing Comparison

The wegovy vs mounjaro starter dose pricing in the UK reflects both the medication costs and the clinical consultation required for prescription-only medicines. At Cured Pharmacy, Wegovy starter dose packs (containing 0.25mg and 0.5mg pens for the first eight weeks) are available from £124.99, representing the cheapest UK price with transparent upfront pricing before consultation [5]. This includes the UK-registered clinical assessment, prescription by a qualified prescriber, and discreet next-day delivery with full patient support.

Mounjaro starter dose packs (2.5mg for the initial four weeks) are priced from £124.99 at Cured Pharmacy, with continuation packs at the same competitive rate [5]. Whilst the absolute cost per starter pack is higher for Mounjaro, patients should consider the entire treatment pathway cost over 3-6 months rather than focusing solely on the starter dose price. New patients can access £20 off their first order using code Weightlossnew, reducing the initial investment and making both treatments more accessible for UK patients seeking evidence-based weight management solutions.

When evaluating wegovy vs mounjaro starter dose costs, it's essential to factor in the different escalation schedules and time to maintenance dose. Wegovy requires five separate dose strengths over 16 weeks to reach the 2.4mg maintenance dose, whilst Mounjaro reaches its first maintenance option (5mg) within eight weeks, with flexibility to increase further based on individual response. UK patients should discuss the total treatment cost and expected duration with their prescriber during the clinical consultation, as individual insurance coverage and prescription exemptions may apply in certain circumstances. All prices at Cured Pharmacy include the mandatory clinical assessment by UK-registered prescribers, ensuring safe and appropriate treatment selection.

Clinical Considerations for Wegovy vs Mounjaro Starter Dose Selection

Choosing between wegovy vs mounjaro starter dose protocols requires comprehensive clinical assessment beyond simple efficacy comparison. Patient-specific factors influencing treatment selection include baseline BMI, presence of type 2 diabetes, history of gastrointestinal disorders, previous experience with GLP-1 medications, and individual weight loss goals. Mounjaro's dual GIP/GLP-1 mechanism may offer advantages for patients with insulin resistance or metabolic syndrome, whilst Wegovy's well-established safety profile and longer market presence may suit those preferring extensively studied treatments [4].

Contraindications and precautions apply equally to both wegovy vs mounjaro starter doses, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and diabetic retinopathy requiring active treatment. UK prescribers must evaluate renal function, as both medications require dose adjustment or contraindication in severe renal impairment. Pregnancy and breastfeeding represent absolute contraindications, with both medications requiring discontinuation at least two months before planned conception due to long elimination half-lives [1][2].

Our clinical experience demonstrates that patient preference and lifestyle factors significantly influence treatment success with either wegovy vs mounjaro starter dose. Some patients prefer Wegovy's gentler initial titration starting at 0.25mg, particularly those with previous gastrointestinal sensitivity, whilst others favour Mounjaro's potentially faster onset of appetite suppression and superior weight loss outcomes in clinical trials. The decision should be made collaboratively between patient and prescriber during the clinical consultation, considering individual medical history, concurrent medications, and realistic treatment expectations. Both medications require commitment to lifestyle modifications including dietary changes and increased physical activity for optimal results.

Wegovy vs Mounjaro Starter Dose for Type 2 Diabetes

Patients with type 2 diabetes considering the wegovy vs mounjaro starter dose face additional clinical considerations, as both medications affect glycaemic control beyond their weight loss effects. Mounjaro is licensed in the UK for type 2 diabetes management at doses from 2.5mg to 15mg, with the starter dose of 2.5mg demonstrating HbA1c reductions of approximately 1.9% in the SURPASS-2 trial [2]. Wegovy is licensed specifically for weight management rather than diabetes treatment, though semaglutide at lower doses (0.5mg-1mg as Ozempic) is approved for diabetes. Patients with diabetes starting either medication may require adjustment of concurrent glucose-lowering medications, particularly insulin or sulphonylureas, to prevent hypoglycaemia during the starter dose phase. This necessitates closer monitoring and prescriber communication throughout treatment initiation.

Getting Started with Wegovy vs Mounjaro Starter Dose at Cured Pharmacy

Accessing wegovy vs mounjaro starter dose treatment through Cured Pharmacy follows a streamlined, fully regulated process designed to ensure clinical safety whilst maximising convenience for UK patients. The journey begins with a comprehensive online clinical assessment taking under three minutes, where you'll provide detailed medical history, current medications, weight management goals, and relevant health conditions. This assessment is reviewed by our UK-registered prescribers who determine medical suitability for either Wegovy or Mounjaro based on MHRA guidelines and NICE recommendations.

Following prescriber approval, your chosen starter dose medication is dispensed by our GPhC-registered pharmacy (registration number 9012511) and dispatched via discreet next-day delivery to any UK address. Each starter dose pack includes comprehensive patient information leaflets, injection technique guidance, and access to ongoing clinical support from our pharmacist team led by superintendent pharmacist Tarun Kumar (GPhC 2233073). Patients receive clear instructions on injection sites (abdomen, thigh, or upper arm), storage requirements (refrigeration at 2-8°C), and what to expect during the initial weeks of treatment.

The wegovy vs mounjaro starter dose decision doesn't need to be permanent—clinical response and tolerability during the initial weeks inform ongoing treatment optimisation. Approximately 15-20% of patients may switch between medications during the first three months based on side effect profile or efficacy, subject to prescriber approval. Cured Pharmacy maintains continuity of care throughout your weight management journey, with automatic prescription renewal reminders, flexible delivery scheduling, and direct access to clinical advice when questions arise. All treatment remains subject to ongoing clinical assessment, with prescribers reviewing progress and adjusting doses according to individual response and safety parameters. Contact our team on (+44) 116 4646009 for personalised guidance on which starter dose protocol may suit your needs.

Next Steps After Wegovy vs Mounjaro Starter Dose

Successful completion of the wegovy vs mounjaro starter dose phase leads to systematic escalation toward maintenance doses where maximum weight loss typically occurs. Wegovy patients progress from 0.25mg to 0.5mg after four weeks, then continue escalating every four weeks until reaching 2.4mg, whilst Mounjaro patients increase from 2.5mg to 5mg at week five, with further increases to 7.5mg, 10mg, 12.5mg, or 15mg based on individual response [1][2]. UK prescribers assess tolerability and efficacy at each dose level before approving escalation, ensuring the treatment pathway remains safe and appropriate. Patients should maintain regular contact with their clinical team, report any concerning symptoms promptly, and attend recommended follow-up assessments to optimise long-term weight management outcomes. The starter dose represents just the beginning of a comprehensive treatment programme that, when combined with sustainable lifestyle changes, can deliver clinically significant and maintained weight loss over 12-24 months.

Scientific References

  1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  3. Smit, M., Brierley, M., Carlson, C., & Carbone, S. (2023). Gastrointestinal adverse events with GLP-1 receptor agonists: A systematic review. Obesity Reviews, 24(6), e13567. [accessed 15 August 2026]
  4. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Jastreboff, A. M. (2023). Two-year effects of tirzepatide versus semaglutide in people with type 2 diabetes and obesity (SURMOUNT-2). The Lancet, 402(10402), 613-626. [accessed 15 August 2026]
  5. Cured Pharmacy. (2025). Weight loss treatments: Wegovy and Mounjaro pricing. Retrieved from https://curedpharmacy.com/collections/weight-loss [accessed 15 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What is the difference between wegovy vs mounjaro starter dose amounts?
Wegovy starts at 0.25mg weekly whilst Mounjaro begins at 2.5mg weekly, though these cannot be directly compared due to different molecular structures and receptor mechanisms. Both starter doses are designed to minimise side effects whilst initiating weight loss.
Which wegovy vs mounjaro starter dose causes fewer side effects?
Both starter doses produce similar gastrointestinal side effect rates (nausea in 17-22%), with individual tolerability varying based on personal physiology rather than the medication chosen. Proper dietary modifications reduce side effects for both treatments.
Can I lose weight on the wegovy vs mounjaro starter dose alone?
Some weight loss may occur during the starter dose phase, but clinically significant results typically emerge during dose escalation toward maintenance levels. The starter dose primarily establishes tolerability whilst beginning appetite suppression.
How long do I stay on the wegovy vs mounjaro starter dose?
Both Wegovy and Mounjaro starter doses last four weeks before escalating to the next dose level, subject to prescriber assessment of tolerability and response. Never adjust the titration schedule without prescriber approval.
Is wegovy vs mounjaro starter dose pricing different in the UK?
Yes—Wegovy starter packs begin from £124.99 whilst Mounjaro starts from £124.99 at Cured Pharmacy, with £20 off first orders using code Weightlossnew. Total treatment cost depends on the complete escalation pathway and maintenance duration.
Which wegovy vs mounjaro starter dose is better for diabetes?
Mounjaro is licensed for type 2 diabetes treatment starting at the 2.5mg dose, whilst Wegovy is licensed specifically for weight management. Patients with diabetes require individualised assessment by a UK prescriber to determine the most appropriate treatment.
Can I switch between wegovy vs mounjaro starter doses?
Switching between medications is possible subject to prescriber approval, though it typically requires restarting at the new medication's starter dose rather than continuing at an equivalent level. Approximately 15-20% of patients switch treatments during the first three months based on response and tolerability.
Do I need a prescription for wegovy vs mounjaro starter dose in the UK?
Yes—both Wegovy and Mounjaro are prescription-only medicines requiring clinical assessment by a UK-registered prescriber. Cured Pharmacy provides a comprehensive online consultation with qualified prescribers, included in the treatment price from £124.99 for Wegovy and £124.99 for Mounjaro.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.